Navigation Links
Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results
Date:8/14/2009

attributable to lower Intermezzo(R) development costs, the majority of which were incurred prior to the submission of the NDA on September 30, 2008. Research and development expenses included non-cash stock compensation expense in accordance with Statement of Financial Accounting Standards No. 123R (SFAS No. 123R) of approximately $108,000 for the quarter ended June 30, 2009 and $66,000 for the quarter ended June 30, 2008.

General and administrative expenses for the quarter ended June 30, 2009 were approximately $5.02 million, compared to approximately $1.71 million for the same period in 2008. The $3.31 million increase consists primarily of higher professional fees to operate as a public company and to negotiate our collaboration with Purdue, increased personnel costs primarily in marketing and administration, increased marketing expenses as we prepared to commercialize Intermezzo(R) and an increase in operational expenses associated with the addition of the Novacea office space in South San Francisco. General and administrative expenses included non-cash stock compensation expense in accordance with SFAS No. 123R of approximately $225,000 for the quarter ended June 30, 2009, as compared to $80,000 for the quarter ended June 30, 2008.

Net loss for the quarter ended June 30, 2009 was approximately $7.1 million or $0.54 per share, compared to a net loss of approximately $4.5 million or $12.09 per share for the quarter ended June 30, 2008. The weighted average common shares used to calculate earnings per share were 13,070,211 and 372,849 respectively for the quarters ended June 30, 2009 and 2008. At June 30, 2009 there were 13,075,401 common shares outstanding and 2,247,664 outstanding options, warrants and common stock subject to repurchase.

Six months ended June 30, 2009 Financial Results

Research and development expenses for the six months ended June 30, 2009 were a
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Transcept Pharmaceuticals to Report Second Quarter 2009 Results
2. Transcept Pharmaceuticals to Hold Conference Call on Agreement with Purdue Pharmaceutical Products L.P. to Commercialize Intermezzo(R) in the United States
3. Transcept Pharmaceuticals to Present at BMO Capital Markets Healthcare Conference on August 5, 2009
4. Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo(R)
5. Transcept Pharmaceuticals to Present at Needham Life Sciences Conference on June 10, 2009
6. Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association
7. Transcept Pharmaceuticals Reports First Quarter 2009 Financial Results
8. Transcept Pharmaceuticals Appoints Joseph T. Kennedy as General Counsel
9. Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results
10. Transcept Pharmaceuticals to Report Fourth Quarter 2008 Results
11. Transcept Pharmaceuticals to Present at Two Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2014)... Studio B Dental in Toronto now offers All-on-Four dental ... a Day, gives patients the opportunity to replace their damaged ... whites with very little recovery time and no bone grafting. ... like natural teeth, and require no special care beyond the ... is one of the premiere dental experts on All-on-Four implants ...
(Date:7/26/2014)... According to the Banish My Bumps Pdf review ... that covers detailed instructions on how to eliminate ... any medication. , Vkool reveals in its review ... for relieving symptoms of keratosis pilaris quickly. In addition, ...     How to treat children's keratosis pilaris ,     How ...
(Date:7/25/2014)... (PRWEB) July 26, 2014 PersonalInjurySolicitorsIreland, ... legal help to people who have suffered from ... launch of both their new company, and a ... on the new website explained, http://www.personalinjurysolicitorsireland.com/personal-injury-claims , ... The focus of the company is always on ...
(Date:7/25/2014)... TX (PRWEB) July 25, 2014 American ... accidents or unexpected collisions can pay higher premiums for ... enhanced its local insurer network to provide SR22 insurance ... . , The different coverage network of local ... has expanded the search platform now publicly available for ...
(Date:7/25/2014)... Ohio (PRWEB) July 25, 2014 Consuming ... foods? How to know? , Read the labels! , ... and determine how it relates to health during a ... p.m. Aug. 1 at Humility House, 755 Ohltown Road, ... will lead an informational discussion and answer questions. ...
Breaking Medicine News(10 mins):Health News:Studio B Dental Improves Patient Smiles with All-on-Four Dental Implants 2Health News:Banish My Bumps Pdf Review Exposes Angela Steinberg's Keratosis Pilaris Treatment Plan – Vkool.com 2Health News:Banish My Bumps Pdf Review Exposes Angela Steinberg's Keratosis Pilaris Treatment Plan – Vkool.com 3Health News:PersonalInjurySolicitorsIreland.com Announces the Launch of their New Company and Website 2Health News:SR22 Insurance for High Risk Motorists Added to Local Quotes System at Insurer Website Online 2Health News:Learn to Decipher Food Labels at Humility House 2
... had developed new technology to use transistors in devices ... ,The biosensor technology was developed by a ... Science and Technology. ,"We proved that transistors ... for devices that convert biological responses into electrical signals," ...
... First Lady of the United States, Laura Bush arrived in the ... Africa tour to bolster the US government's anti AIDS and malaria ... President Abdoulaye Wade's wife Viviane. ,From Senegal she is ... a five-day long trip to the continent which will also focus ...
... study published on bmj.com today (Tuesday 26 June) ... patients with well-controlled, non-insulin dependent (type 2) diabetes. ... the American Diabetes Association Conference, suggests that current ... reviewed. ,Non-insulin dependent (type 2) diabetes ...
... observed as the National Testing Day in the US. ... produced by the National Association of People with AIDS ... HIV counseling and testing. ,The Centers for ... 280,000 people nationwide are HIV-positive but are unaware of ...
... celebrating annual Monsoon festival, which marks San Joao, the feast ... a legacy Goans have inherited from the Portuguese, who ruled ... ,During the celebrations, Goans jumped into rivers, ponds and wells ... celebrated with much traditional fervour. ,At Loutulim in ...
... for Evolutionary Anthropology, Leipzig, Germany, have investigated evidence of ... about altruism are often based on the assumption that ... human version differs from that of other animals in ... colleagues have found evidence that chimpanzees act altruistically toward ...
Cached Medicine News:Health News:Questions Over Value of Glucose Monitoring for Non-insulin Using Diabetes Patients 2Health News:US Officials Urge Testing for HIV as Health Crisis Intensifies 2Health News:US Officials Urge Testing for HIV as Health Crisis Intensifies 3Health News:Goans Celebrate Monsoon Festival 2
(Date:7/25/2014)... Tobago , July 25, 2014  The ... & Tobago Ministry of Health approved the introduction ... significantly increases the cure rate from Hepatitis C, ... the genotype 1 virus. Telaprevir is available in ... brand INCIVO®. Photo - http://www2.prnewswire.com.br/imgs/pub/2014-07-25/original/2026.jpg ...
(Date:7/25/2014)...  Acsis Inc., the market leader for supply ... recently posted an article, "Future of Running ... needs for companies, extended supply chain, and explains ... no longer work today.  The article explains how ... mobile technology, machine to machine (M2M) connectivity, and ...
(Date:7/25/2014)... 25, 2014 According to a ... and China Insulin Market (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, Premixed, ... Growth, Trends and Forecast (Value and Volume), 2013 - ... 19.99 billion in 2012 and is expected to grow ... to reach USD 32.24 billion in 2019. ...
Breaking Medicine Technology:The Hepatitis C virus is the main cause of liver transplant in the world 2The Hepatitis C virus is the main cause of liver transplant in the world 3Acsis Addresses Questions on the Modern Supply Chain 2Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 2Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 3Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 4
... MOUNTAIN VIEW, Calif. , July 29 IRIDEX Corporation (Nasdaq: IRIX ... the market closes on Thursday, August 5, 2010 . ... investment community at 5:00 p.m. Eastern Time on ... of the quarter and other business developments. , ...
... SAVANNAH, Ga. , July 29 MIT Holding, Inc. announces ... of the board of directors. MIT Holding, Inc. founder William "Rocky" Parker ... , , , ... being the senior managing director of Drakeford & Drakeford for the past ...
Cached Medicine Technology:IRIDEX Announces Second Quarter 2010 Conference Call and Release Date 2Walter H.C. Drakeford Named Co-President and Co-Chairman of the Board of Directors for MIT Holding, Inc. 2
... The complete line of Surgical Access ... ,The OnePort™ trocar system is actually ... be versatile, operationally flexible and clinically adaptive ... offering options in disposability and bladed or ...
... FPK01 Thoracic Trocar Pak contains: ... flexible sleeves and (1) 12mm ... ,FPK02 Thoracic Trocar Pak contains: ... flexible sleeves., ,FPK03 Thoracic ...
... The Thoracic Trocar Sleeve consists ... which is designed to prevent ... structures once the cavity has ... stability threads on the sleeve ...
... believe that the trocar should be a ... precision and speeding the process. So we ... that meets the needs of the most ... - The only trocar that affords the ...
Medicine Products: